AR118790A1 - Composición de naproxeno en mini cápsula blanda - Google Patents
Composición de naproxeno en mini cápsula blandaInfo
- Publication number
- AR118790A1 AR118790A1 ARP200101172A ARP200101172A AR118790A1 AR 118790 A1 AR118790 A1 AR 118790A1 AR P200101172 A ARP200101172 A AR P200101172A AR P200101172 A ARP200101172 A AR P200101172A AR 118790 A1 AR118790 A1 AR 118790A1
- Authority
- AR
- Argentina
- Prior art keywords
- naproxen
- mini
- mini soft
- gelatin capsules
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
En el presente documento se divulgan mini cápsulas blandas de gelatina que comprenden un producto de reacción de ácido libre de naproxeno e hidróxido de potasio en una relación molar de hidróxido de potasio a ácido libre de naproxeno de menos de aproximadamente 1. También se divulgan en el presente documento métodos para tratar pacientes que lo necesitan con las mini cápsulas blandas de gelatina, así como métodos para estabilizar mini cápsulas blandas de gelatina que incluyen una composición de relleno que tiene una alta concentración de agente activo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962839198P | 2019-04-26 | 2019-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR118790A1 true AR118790A1 (es) | 2021-11-03 |
Family
ID=72941368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP200101172A AR118790A1 (es) | 2019-04-26 | 2020-04-24 | Composición de naproxeno en mini cápsula blanda |
Country Status (14)
Country | Link |
---|---|
US (1) | US20220202751A1 (es) |
EP (1) | EP3958852A4 (es) |
JP (1) | JP2022530468A (es) |
KR (1) | KR20220004691A (es) |
CN (1) | CN113950324A (es) |
AR (1) | AR118790A1 (es) |
AU (1) | AU2020263295A1 (es) |
BR (1) | BR112021021414A2 (es) |
CA (1) | CA3138131A1 (es) |
CO (1) | CO2021015117A2 (es) |
IL (1) | IL287590A (es) |
MX (1) | MX2021013106A (es) |
TW (1) | TW202106291A (es) |
WO (1) | WO2020219499A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240037990A (ko) * | 2021-07-06 | 2024-03-22 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 소프트겔 캡슐 |
CN115887407B (zh) * | 2022-12-29 | 2023-08-18 | 深圳市泰力生物医药有限公司 | 一种西罗莫司软胶囊及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5071643A (en) * | 1986-10-17 | 1991-12-10 | R. P. Scherer Corporation | Solvent system enhancing the solubility of pharmaceuticals for encapsulation |
US6387400B1 (en) * | 2000-08-29 | 2002-05-14 | R.P. Scherer Technologies, Inc. | Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
US6689382B2 (en) * | 2002-05-15 | 2004-02-10 | Procaps S.A. | Soft shell gelatin capsules containing non-steroidal anti-inflammatories |
US20070053868A1 (en) * | 2005-03-08 | 2007-03-08 | Banner Pharmacaps, Inc. | Solvent system for enhancing the solubility of pharmaceutical agents |
CA2690488C (en) * | 2010-01-19 | 2013-06-11 | Accucaps Industries Limited | Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof |
-
2020
- 2020-04-22 KR KR1020217038149A patent/KR20220004691A/ko unknown
- 2020-04-22 MX MX2021013106A patent/MX2021013106A/es unknown
- 2020-04-22 CA CA3138131A patent/CA3138131A1/en active Pending
- 2020-04-22 US US17/594,677 patent/US20220202751A1/en active Pending
- 2020-04-22 JP JP2021563331A patent/JP2022530468A/ja active Pending
- 2020-04-22 WO PCT/US2020/029234 patent/WO2020219499A1/en unknown
- 2020-04-22 EP EP20794617.9A patent/EP3958852A4/en active Pending
- 2020-04-22 BR BR112021021414A patent/BR112021021414A2/pt unknown
- 2020-04-22 AU AU2020263295A patent/AU2020263295A1/en active Pending
- 2020-04-22 CN CN202080041755.XA patent/CN113950324A/zh active Pending
- 2020-04-24 TW TW109113937A patent/TW202106291A/zh unknown
- 2020-04-24 AR ARP200101172A patent/AR118790A1/es unknown
-
2021
- 2021-10-26 IL IL287590A patent/IL287590A/en unknown
- 2021-11-09 CO CONC2021/0015117A patent/CO2021015117A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA3138131A1 (en) | 2020-10-29 |
AU2020263295A1 (en) | 2021-11-18 |
IL287590A (en) | 2021-12-01 |
US20220202751A1 (en) | 2022-06-30 |
CN113950324A (zh) | 2022-01-18 |
KR20220004691A (ko) | 2022-01-11 |
CO2021015117A2 (es) | 2021-11-19 |
EP3958852A4 (en) | 2023-01-18 |
BR112021021414A2 (pt) | 2022-02-15 |
MX2021013106A (es) | 2022-01-24 |
JP2022530468A (ja) | 2022-06-29 |
TW202106291A (zh) | 2021-02-16 |
WO2020219499A1 (en) | 2020-10-29 |
EP3958852A1 (en) | 2022-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2021015117A2 (es) | Composición de naproxeno en cápsula blanda miniatura | |
PE20170188A1 (es) | Formulaciones y metodos de tratamiento con queratina | |
BR112017022021A2 (pt) | aplicação de agente anticaspa solúvel em tensoativo | |
CL2017001488A1 (es) | Benzamidas sustituidas con 1,3–tiazol–2–ilo | |
PE20131324A1 (es) | Formulacion subcutanea de anticuerpo anti-her2 | |
BR112017018383A2 (pt) | inclusão de éxon2 induzida por anti-sentido em alfa-glucosidase ácida | |
BR112018069251A2 (pt) | métodos de intervenção precoce para prevenir ou melhorar a toxicidade | |
CR11723A (es) | Agente para tratar enfermedad | |
AR081364A1 (es) | Composiciones farmaceuticas de pazopanib y metodos para su elaboracion | |
UY31816A (es) | Agente para el tratamiento y/o prevención de una enfemedad autoinmune y para la formación de células t reguladoras | |
PE20061107A1 (es) | Composiciones de tigeciclina y metodos para su preparacion | |
CL2019001447A1 (es) | Preparación de complejos sólidos de ciclodextrina para suministro de ingredientes farmacéuticos activos oftálmicos. | |
AR083395A1 (es) | Derivado peptidico nmu (neuromedina u) con elevado efecto anorectico | |
CR20120400A (es) | Pastillas de gelatina blanda con nicotina | |
BR112015014006A2 (pt) | composições de cuidado oral estáveis ao peróxido | |
AR087911A1 (es) | Metodos en multiples etapas y composiciones para desensibilizar las caras de formaciones subterraneas | |
CL2020003276A1 (es) | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias | |
CL2004000899A1 (es) | Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion. | |
CR20150310A (es) | Solución para preservar conductos vasculares | |
CO2019004814A2 (es) | Terapias combinadas para la ateroesclerosis, incluyendo la enfermedad cardiovascular ateroesclerótica | |
AR082155A1 (es) | Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido | |
CR20170142A (es) | Composiciones farmacéuticas resistentes al abuso | |
CL2021000998A1 (es) | Agentes de liberación de gas antimicrobianos y sistemas y métodos para utilizarlos | |
AR089736A1 (es) | Particula para el suministro de un beneficio, proceso para preparar dicha particula, composiciones que comprenden dichas particulas y un metodo para tratar sustratos | |
AR088918A1 (es) | Composiciones antitranspirantes anhidras |